Issuer name: Hexagon Purus ASAEx. date: 18 May 2026Type of corporate action: Reverse share splitReverse share split ratio: 10:1, where ten (10) old shares give one (1) new share. New par value per share: NOK 1New ISIN for the Company’s shares: NO0013751966 This information is published in accordance with the requirements of the Continuing Obligations

PRESS RELEASE REGULATED INFORMATIONBrussels, 18 May 2026, 07:55 AMNEXTENSA STRENGTHENS BALANCE SHEET AND ADVANCES KEY DEVELOPMENTS IN Q1 2026Brussels, 18 May 2026 – Nextensa delivered a strong first quarter of 2026, marked by key transactions, including the disposal of Gewerbepark Stadlau in Vienna. Following the quarter-end, additional major milestones were achieved, including the sale of The Rock and the B&B Hotel in Cloche d’Or, as well as the obtaining of the urban planning and environmental permit for Lake Side at Tour & Taxis.Q1 2026 higlightsSale of Gewerbepark Stadlau (Vienna) for €35.45 million Net financial debt reduced to €571.8 million Continued strong progress in development pipeline (Cloche d’Or & Tour & Taxis) Net profit increased to €9.6 millionPost quarter-end highlights Forward sale of...

Sampo plc, stock exchange release, 18 May 2026 at 8:30 am EEST Sampo plc’s share buybacks week 20/2026 During week 20 (11 May 2026 – 15 May 2026), Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:Market (MIC Code) Daily volume (in number of shares) and weighted average price of the purchased shares, EUR* Aggregated weekly volume (in number of shares) and weighted weekly average price of the purchased shares, EUR*    11/05/2026 12/05/2026 13/05/2026 14/05/2026 15/05/2026 Week 20/2026, totalAQEU Volume 3,335 4,248 2,850 0 3,786 14,219Average price 8.87 8.87 8.89 0.00 9.00 8.91CEUX Volume 159,670 150,727 144,078 0 142,487 596,962Average price 8.89 8.91 8.90 0.00 8.99 8.92TQEX Volume 47,523 46,885 40,441 0 32,934 167,783Average price 8.89 8.92 8.90 0.00 9.00 8.92XHEL Volume 252,296 241,206 263,784 0 194,711 951,997Average...

Ipsen initiates a new share buy-back program PARIS, FRANCE, 18 MAY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has appointed an investment services provider to purchase an aggregate number of up to 350,000 Ipsen S.A. shares, representing approximately 0.42% of the share capital, over a maximum period of six months. The shares purchased under this agreement will be allocated mainly to cover Ipsen’s free employee share-allocation plan and its new employee share-ownership plan. This program is made pursuant to the authorization granted by the Company’s Annual General Meeting, held on 13 May 2026. About IpsenWe are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal...

ATLANTA, May 18, 2026 (GLOBE NEWSWIRE) — Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that it has initiated a voluntary Chapter 11 process in the U.S. Bankruptcy Court for the Southern District of Texas to effect an orderly wind-down of the Company’s operations and facilitate a sale of its assets. “Over time, the Company has continued to strengthen its protocols and procedures to combat fraud and protect the customers who use its BTMs, including enhanced identity verification, customer fraud warnings, and its more recent adoption of lower transaction limits for its customers,” said Alex Holmes, CEO of Bitcoin Depot. “Nevertheless, the regulatory environment for BTM operators has shifted significantly: states have imposed increasingly stringent compliance obligations,...

SAN FRANCISCO, May 17, 2026 (GLOBE NEWSWIRE) — Life360, Inc. (NASDAQ: LIF; ASX: 360), the provider of the market-leading family safety and connection mobile application, today announced that its Board of Directors has authorized management’s deployment of a multi-year share repurchase program of up to $225 million (the “Program”). The objective of the Program is designed to return value to our shareholders by minimizing dilution from stock-based instruments. The Program represents a productive deployment of the Company’s capital, supported by a strong balance sheet and twelve consecutive quarters of positive operating cash flow. “We remain focused on investing in the Life360 platform as we grow our global member base and deepen the value we deliver to families,” said Life360 Chief Executive Officer Lauren Antonoff. “This targeted...

CARLSBAD, Calif., May 17, 2026 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, will announce data from the ongoing Phase 1/2 RESTORE-FA trial evaluating DT-216P2 in patients with Friedreich’s ataxia (FA) on Monday, May 18, 2026. Management will host a conference call and webcast at 8:00 a.m. ET. A live webcast of the presentation will be available here and in the investors section of the company’s website at www.designtx.com. The webcast will be archived for at least 30 days following the presentation. About Design TherapeuticsDesign Therapeutics is a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC® gene targeted chimera small molecules. The company’s GeneTAC®...

More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep PSA reduction higher in patients receiving Pluvicto combination vs. SoC at 12, 24 and 48 weekssNDA filed in US, China and Japan; decisions expected H2 2026Basel, May 17, 2026 – Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) combined with standard of care (SoC) in PSMA-positive metastatic hormone sensitive prostate cancer (mHSPC). Data were presented as a rapid oral presentation at the American Urological Association Annual Meeting 2026. Results show that patients treated with Pluvicto experienced a higher frequency and depth of PSA response when combined with SoC (androgen receptor pathway...

Eimskip and Faroe Ship have received a notice from the Seafarers’ Union of Iceland (SÍ) announcing an indefinite strike by bosuns and able seamen on the Company’s own vessels Brúarfoss, Dettifoss, and Selfoss, effective from 12:00 PM on Monday, May 25, if an agreement hasn´t been reached before that time. The agreement with SÍ members on the Company’s own vessels expired at the end of last year. During the validity period, the agreement has changed in line with general labor market wage increases under the so-called stability agreement, as well as additional increases agreed for these roles. SÍ had previously announced a temporary strike on the Company’s own vessels scheduled for April 12.-15. which was withdrawn on April 8. A temporary strike by harbor employees, originally announced for April 13, was postponed until the period of May...